Paul R. Edick - 27 Oct 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Director
Signature
/s/ Paul R. Edick
Issuer symbol
VTGN
Transactions as of
27 Oct 2025
Transactions value $
$0
Form type
4
Filing time
04 Nov 2025, 16:34:49 UTC
Previous filing
31 Jan 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Edick Paul R Director C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Paul R. Edick 04 Nov 2025 0001531178

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Award +35.2K 35.2K 27 Oct 2025 Common Stock 35.2K $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant.